PPIDT00113
Drug Information
| Name | Insulin detemir |
|---|---|
| Sequence | GIVEQCCTSICSLYQLENYCN |
| DrugBank_ID | DB01307 |
| Type | biotech |
| Indication | Insulin detemir is indicated to improve glycemic control in adults and children with diabetes mellitus.[L42375] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Implant | Soft tissue |
14.2 mg/1mL
|
| Injection | Subcutaneous |
14.2 mg/1mL
|
| Injection, solution | Parenteral; Subcutaneous |
100 U/ML
|
| Injection, solution | Subcutaneous |
100 [iU]/1mL
|
| Injection, solution | Subcutaneous |
14.2 mg/1mL
|
| Solution | Subcutaneous |
100 U
|
| Solution | Subcutaneous |
1420000 mg
|
| Injection; injection, solution | Subcutaneous |
100 IU/ML
|
| Injection, solution | Subcutaneous |
100 units/mL
|
| Injection, solution | Subcutaneous |
|
| Solution | Subcutaneous |
100 unit / mL
|
| Injection, solution | Subcutaneous |
14.2 mg/ml
|
| Injection, solution | Subcutaneous |
100 U/ml
|
| Solution | Subcutaneous |
100 U/ml
|
| Injection, solution | — |
100 iu/1ml
|
| Solution | Subcutaneous |
100 iu/1ml
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P06213 | INSR | Insulin receptor | Homo sapiens | agonist | Link |
| target | P08069 | IGF1R | Insulin-like growth factor 1 receptor | Homo sapiens | activator | Link |
| enzyme | P05177 | CYP1A2 | Cytochrome P450 1A2 | Homo sapiens | inducer | Link |
| enzyme | P14735 | IDE | Insulin-degrading enzyme | Homo sapiens | substrate | Link |
| carrier | P02768 | ALB | Albumin | Homo sapiens | binder | Link |